-
An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-19 Kok-Siong Chen,Sarah Manoury-Battais,Nobuhiko Kanaya,Ioulia Vogiatzi,Paulo Borges,Sterre J Kruize,Yi-Ching Chen,Laura Y Lin,Filippo Rossignoli,Natalia Claire Mendonca,Khalid Shah
Recent progress in cancer cell-based therapies has led to effective targeting and robust immune responses against cancer. However, the inherent safety risks of using live cancer cells necessitate the creation of an optimized safety switch without hindering the efficacy of immunotherapy. The existing safety switches typically induce tolerogenic cell death, potentially leading to an immunosuppressive
-
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-19 Katherine L Morel,Beatriz Germán,Anis A Hamid,Jagpreet S Nanda,Simon Linder,Andries M Bergman,Henk van der Poel,Ingrid Hofland,Elise M Bekers,Shana Y Trostel,Deborah L Burkhart,Scott Wilkinson,Anson T Ku,Minhyung Kim,Jina Kim,Duanduan Ma,Jasmine T Plummer,Sungyong You,Xiaofeng A Su,Wilbert Zwart,Adam G Sowalsky,Christopher J Sweeney,Leigh Ellis
Phenotypic plasticity is a hallmark of cancer and increasingly realized as a mechanism of resistance to androgen receptor (AR)-targeted therapy. Now that many prostate cancer (PCa) patients are treated upfront with AR-targeted agents, it's critical to identify actionable mechanisms that drive phenotypic plasticity, to prevent the emergence of resistance. We showed that loss of tristetraprolin (TTP
-
G-CSF resistance of ELANE mutant neutropenia depends on SERF1 containing truncated neutrophil elastase aggregates. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-19 Ramesh C Nayak,Sana Emberesh,Lisa Trump,Ashley Wellendorf,Abhishek Singh,Brice Korkmaz,Marshall S Horwitz,Kasiani C Myers,Theodosia A Kalfa,Carolyn Lutzko,Jose A Cancelas
Severe congenital neutropenia (SCN) is frequently associated with dominant point mutations in ELANE, the gene encoding neutrophil elastase (NE). Chronic administration of granulocyte colony-stimulating factor (G-CSF) is a first-line treatment of ELANE-mutant (ELANEmut) SCN. However, some ELANEmut patients including patients with ELANE start codon mutations do not respond to G-CSF. Here, through directed
-
Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent J. Clin. Invest. (IF 13.3) Pub Date : 2024 Vicki V. Stylianou, Kirstie M. Bertram, Van Anh Vo, Elizabeth B. Dunn, Heeva Baharlou, Darcii J. Terre, James Elhindi, Elisabeth Elder, James French, Farid Meybodi, Stéphane T. Temmerman, Arnaud M. Didierlaurent, Margherita Coccia, Kerrie J. Sandgren, Anthony L. Cunningham
Vaccine adjuvants are thought to work by stimulating innate immunity in the draining lymph node (LN), although this has not been proven in humans. To bridge the data obtained in animals to humans, we have developed an in situ human LN explant model to investigate how adjuvants initiate immunity. Slices of explanted LNs were exposed to vaccine adjuvants and revealed responses that were not detectable
-
Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models J. Clin. Invest. (IF 13.3) Pub Date : 2024 Alison C. Livada, Kathleen E. McGrath, Michael W. Malloy, Chen Li, Sara K. Ture, Paul D. Kingsley, Anne D. Koniski, Leah A. Vit, Katherine E. Nolan, Deanne Mickelsen, Grace E. Monette, Preeti Maurya, James Palis, Craig N. Morrell
Lung megakaryocytes (Mks) are largely extravascular with an immune phenotype (1). Because bone marrow (BM) Mks are short lived, it has been assumed that extravascular lung Mks are constantly “seeded” from the BM. To investigate lung Mk origins and how origin affects their functions, we developed methods to specifically label lung Mks using CFSE dye and biotin delivered via the oropharyngeal route.
-
Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma J. Clin. Invest. (IF 13.3) Pub Date : 2024 Yang Liu, Junyan Wu, Hinda Najem, Yiyun Lin, Lizhi Pang, Fatima Khan, Fei Zhou, Heba Ali, Amy B. Heimberger, Peiwen Chen
Tumor-associated macrophages and microglia (TAMs) are critical for tumor progression and therapy resistance in glioblastoma (GBM), a type of incurable brain cancer. We previously identified lysyl oxidase (LOX) and olfactomedin like-3 (OLFML3) as essential macrophage and microglia chemokines, respectively, in GBM. Here, single-cell transcriptomics and multiplex sequential immunofluorescence followed
-
TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M J. Clin. Invest. (IF 13.3) Pub Date : 2024 Yi Zhou, Shu Zhang, Guoteng Qiu, Xue Wang, Andrew Yonemura, Hongwei Xu, Guofei Cui, Shanshan Deng, Joanne Chun, Nianyong Chen, Meng Xu, Xinhua Song, Jingwen Wang, Zijing Xu, Youping Deng, Matthias Evert, Diego F. Calvisi, Shumei Lin, Haichuan Wang, Xin Chen
Activated mTORC2/AKT signaling plays a role in hepatocellular carcinoma (HCC). Research has shown that TSC/mTORC1 and FOXO1 are distinct downstream effectors of AKT signaling in liver regeneration and metabolism. However, the mechanisms by which these pathways mediate mTORC2/AKT activation in HCC are not yet fully understood. Amplification and activation of c-MYC are key molecular events in HCC. In
-
Pharmacological regeneration of sensory hair cells restores afferent innervation and vestibular function J. Clin. Invest. (IF 13.3) Pub Date : 2024 Hanae Lahlou, Hong Zhu, Wu Zhou, Albert S.B. Edge
The sensory cells that transduce the signals for hearing and balance are highly specialized mechanoreceptors called hair cells that together with supporting cells comprise the sensory epithelia of the inner ear. Loss of hair cells from toxin exposure and age can cause balance disorders and is essentially irreversible due to the inability of mammalian vestibular organs to regenerate physiologically
-
Uterine cyclin A2–deficient mice as a model of female early pregnancy loss J. Clin. Invest. (IF 13.3) Pub Date : 2024 Fatimah Aljubran, Katelyn Schumacher, Amanda Graham, Sumedha Gunewardena, Courtney Marsh, Michael Lydic, Kristin Holoch, Warren B. Nothnick
Proper action of the female sex steroids 17β-estradiol (E2) and progesterone (P4) on the endometrium is essential for fertility. Beyond its role in regulating the cell cycle, cyclin A2 (CCNA2) also mediates E2 and P4 signaling in vitro, but a potential role in modulating steroid action for proper endometrial tissue development and function is unknown. To fill this gap in our knowledge, we examined
-
Stimulation of an entorhinal-hippocampal extinction circuit facilitates fear extinction in a post-traumatic stress disorder model J. Clin. Invest. (IF 13.3) Pub Date : 2024 Ze-Jie Lin, Xue Gu, Wan-Kun Gong, Mo Wang, Yan-Jiao Wu, Qi Wang, Xin-Rong Wu, Xin-Yu Zhao, Michael X. Zhu, Lu-Yang Wang, Quanying Liu, Ti-Fei Yuan, Wei-Guang Li, Tian-Le Xu
Effective psychotherapy of post-traumatic stress disorder (PTSD) remains challenging owing to the fragile nature of fear extinction, for which the ventral hippocampal CA1 (vCA1) region is considered as a central hub. However, neither the core pathway nor the cellular mechanisms involved in implementing extinction are known. Here, we unveil a direct pathway, where layer 2a fan cells in the lateral entorhinal
-
Neuropilin-2–expressing breast cancer cells mitigate radiation-induced oxidative stress through nitric oxide signaling J. Clin. Invest. (IF 13.3) Pub Date : 2024 Ayush Kumar, Hira Lal Goel, Christi A. Wisniewski, Tao Wang, Yansong Geng, Mengdie Wang, Shivam Goel, Kai Hu, Rui Li, Lihua J. Zhu, Jennifer L. Clark, Lindsay M. Ferreira, Michael A. Brehm, Thomas J. FitzGerald, Arthur M. Mercurio
The high rate of recurrence after radiation therapy in triple-negative breast cancer (TNBC) indicates that novel approaches and targets are needed to enhance radiosensitivity. Here, we report that neuropilin-2 (NRP2), a receptor for vascular endothelial growth factor (VEGF) that is enriched on subpopulations of TNBC cells with stem cell properties, is an effective therapeutic target for sensitizing
-
Parkin activates innate immunity and promotes antitumor immune responses J. Clin. Invest. (IF 13.3) Pub Date : 2024 Michela Perego, Minjeong Yeon, Ekta Agarwal, Andrew T. Milcarek, Irene Bertolini, Chiara Camisaschi, Jagadish C. Ghosh, Hsin-Yao Tang, Nathalie Grandvaux, Marcus Ruscetti, Andrew V. Kossenkov, Sarah Preston-Alp, Italo Tempera, Noam Auslander, Dario C. Altieri
The activation of innate immunity and associated interferon (IFN) signaling have been implicated in cancer, but the regulators are elusive and links to tumor suppression remain undetermined. Here, we found that Parkin, an E3 ubiquitin ligase altered in Parkinson’s Disease, was epigenetically silenced in cancer and its reexpression by clinically approved demethylating therapy stimulated transcription
-
Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome J. Clin. Invest. (IF 13.3) Pub Date : 2024 Ana Barettino, Cristina González-Gómez, Pilar Gonzalo, María J. Andrés-Manzano, Carlos R. Guerrero, Francisco M. Espinosa, Rosa M. Carmona, Yaazan Blanco, Beatriz Dorado, Carlos Torroja, Fátima Sánchez-Cabo, Ana Quintas, Alberto Benguría, Ana Dopazo, Ricardo García, Ignacio Benedicto, Vicente Andrés
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare disease caused by the expression of progerin, an aberrant protein produced by a point mutation in the LMNA gene. HGPS patients show accelerated aging and die prematurely mainly from complications of atherosclerosis such as myocardial infarction, heart failure, or stroke. However, the mechanisms underlying HGPS vascular pathology remain
-
Single-nuclei transcriptomics reveals TBX5-dependent targets in a patient with Holt-Oram syndrome. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-14 Jeffrey D Steimle,Yi Zhao,Fansen Meng,Mikaela E Taylor,Diwakar Turaga,Iki Adachi,Xiao Li,James F Martin
-
Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+ CD8+ T-cells. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-14 Angelina S Hwang,Jacob A Kechter,Tran H Do,Alysia N Hughes,Nan Zhang,Xing Li,Rachael Bogle,Caitlin M Brumfiel,Meera H Patel,Blake Boudreaux,Puneet Bhullar,Shams Nassir,Miranda L Yousif,Alyssa L Stockard,Zachary Leibovit-Reiben,Ewoma Ogbaudu,David J DiCaudo,Jennifer Fox,Mehrnaz Gharaee-Kermani,Xianying Xing,Samantha Zunich,Emily Branch,J Michelle Kahlenberg,Allison C Billi,Olesya Plazyo,Lam C Tsoi,Mark
BACKGROUND Cutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that interrupts the signaling pathway of interferon gamma (IFN)-γ, a cytokine implicated in the pathogenesis of LP. METHODS In this phase II trial, twelve patients with
-
Complement-producing maternal microchimeric cells override infection susceptibility in complement-deficient murine offspring. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-14 Giang Pham,Raymond E Diep,Lucien H Turner,David B Haslam,Sing Sing Way
-
MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancer. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-12 Yuwen Cai,Cui-Cui Liu,Yanwu Zhang,Yiming Liu,Lie Chen,Xin Xiong,Zhiming Shao,Ke-Da Yu
Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer, the most common type of breast cancer, is facing challenges such as endocrine therapy resistance and distant relapse. Immunotherapy has shown progress in treating triple-negative breast cancer, but immunological research on HR+/HER2- breast cancer is still in its early stages. Here, we performed
-
Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-12 Sara Ancel,Joris Michaud,Eugenia Migliavacca,Charline Jomard,Aurélie Fessard,Pauline Garcia,Sonia Karaz,Sruthi Raja,Guillaume E Jacot,Thibaut Desgeorges,José-Luis Sánchez-García,Loic Tauzin,Yann Ratinaud,Benjamin Brinon,Sylviane Métairon,Lucas Pinero,Denis Barron,Stephanie Blum,Leonidas G Karagounis,Ramin Heshmat,Afshin Ostovar,Farshad Farzadfar,Isabella Scionti,Rémi Mounier,Julien Gondin,Pascal Stuelsatz
Skeletal muscle relies on resident muscle stem cells (MuSCs) for growth and repair. Aging and muscle diseases impair MuSC function, leading to stem cell exhaustion and regenerative decline that contribute to the progressive loss of skeletal muscle mass and strength. In the absence of clinically available nutritional solutions specifically targeting MuSCs, we used a human myogenic progenitor (hMP) high-content
-
Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-12 Wenli Liu,Brian D Hardaway,Eunyoung Kim,Jessica Pauli,Justus Leonard Wettich,Mustafa Yalcinkaya,Cheng-Chieh Hsu,Tong Xiao,Muredach P Reilly,Ira Tabas,Lars Maegdefessel,Kai Schlepckow,Haass Christian,Nan Wang,Alan R Tall
Clonal hematopoiesis (CH) increases inflammasome-linked atherosclerosis but the mechanisms by which CH mutant cells transmit inflammatory signals to non-mutant cells are largely unknown. To address this question we transplanted 1.5% Jak2VF bone marrow (BM) cells with 98.5% WT BM cells into hyperlipidemic Ldlr-/- mice. Low allele burden (LAB) mice showed accelerated atherosclerosis with increased features
-
In utero human cytomegalovirus infection expands NK-like FcγRIII+ CD8+ T cells that mediate Fc antibody functions. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-12 Eleanor C Semmes,Danielle R Nettere,Ashley N Nelson,Jillian H Hurst,Derek W Cain,Trevor D Burt,Joanne Kurtzberg,R Keith Reeves,Carolyn B Coyne,Genevieve G Fouda,Justin Pollara,Sallie R Permar,Kyle M Walsh
Human cytomegalovirus (HCMV) profoundly impacts host T and natural killer (NK) cells across the lifespan, yet how this common congenital infection modulates developing fetal immune cell compartments remains underexplored. Using cord blood from neonates with and without congenital HCMV (cCMV) infection, we identify an expansion of Fcγ receptor III (FcγRIII)-expressing CD8+ T cells following HCMV exposure
-
Prospective observational study and mechanistic evidence showing lipolysis of circulating triglycerides worsens hypertriglyceridemic acute pancreatitis. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-07 Prasad Rajalingamgari,Biswajit Khatua,Megan J Summers,Sergiy Kostenko,Yu-Hui H Chang,Mohamed Elmallahy,Arti Anand,Anoop Narayana Pillai,Mahmoud Morsy,Shubham Trivedi,Bryce McFayden,Sarah Jahangir,Christine Lh Snozek,Vijay P Singh
BACKGROUND While most hypertriglyceridemia is asymptomatic, hypertriglyceridemia-associated acute pancreatitis (HTG-AP) can be more severe than other AP etiologies. The reasons underlying this are unclear. We thus studied whether lipolytic generation of non-esterified fatty acids (NEFA) from circulating triglycerides (TGs) could worsen clinical outcomes. METHODS Admission serum TGs, NEFA compositions
-
Progranulin-dependent repair function of Regulatory T cells drive bone fracture healing. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-07 Ruiying Chen,Xiaomeng Zhang,Bin Li,Maurizio S Tonetti,Yijie Yang,Yuan Li,Beilei Liu,Shujiao Qian,Yingxin Gu,Qingwen Wang,Kairui Mao,Hao Cheng,Hongchang Lai,Junyu Shi
Local immunoinflammatory events instruct skeletal stem cells (SSCs) to repair/regenerate bone after injury, but mechanisms are incompletely understood. We hypothesized that specialized Regulatory T (Treg) cells are necessary for bone repair and interact directly with SSCs through organ-specific messages. Both in human patients with bone fracture and mouse model of bone injury, we identified a bone
-
68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer. J. Clin. Invest. (IF 13.3) Pub Date : 2024-11-07 Haojun Chen,Liang Zhao,Yizhen Pang,Jiyun Shi,Hannan Gao,Yining Sun,Jianhao Chen,Hao Fu,Jiayu Cai,Lingyu Yu,Ru Zeng,Long Sun,Hua Wu,Zhanxiang Wang,Fan Wang
Background Considering trophoblast cell surface antigen 2 (Trop2) is overexpressed in a wide range of human epithelial cancers, it presents an attractive target for the diagnosis and treatment of multiple types of cancer. Herein, we have developed a Trop2-specific radiotracer, 68Ga-MY6349, and present a prospective, investigator-initiated trial to explore the clinical values of 68Ga-MY6349 PET/CT.
-
RNASEH2B loss and PARP inhibition in advanced prostate cancer J. Clin. Invest. (IF 13.3) Pub Date : 2024 Juliet Carmichael, Ines Figueiredo, Bora Gurel, Nick Beije, Wei Yuan, Jan Rekowski, George Seed, Suzanne Carreira, Claudia Bertan, Maria de Los Dolores Fenor de La Maza, Khobe Chandran, Antje Neeb, Jon Welti, Lewis Gallagher, Denisa Bogdan, Mateus Crespo, Ruth Riisnaes, Ana Ferreira, Susana Miranda, Jinqiu Lu, Michael M. Shen, Emma Hall, Nuria Porta, Daniel Westaby, Christina Guo, Rafael Grochot, Christopher
BACKGROUND. Clinical trials have suggested antitumor activity from PARP inhibition beyond homologous recombination deficiency (HRD). RNASEH2B loss is unrelated to HRD and preclinically sensitizes to PARP inhibition. The current study reports on RNASEH2B protein loss in advanced prostate cancer and its association with RB1 protein loss, clinical outcome, and clonal dynamics during treatment with PARP
-
PAC1 constrains type 2 inflammation through promotion of CGRP signaling in ILC2s J. Clin. Invest. (IF 13.3) Pub Date : 2024 Yuan Jin, Bowen Liu, Qiuyu Li, Xiangyan Meng, Xiaowei Tang, Yan Jin, Yuxin Yin
Dysfunction of group 2 innate lymphoid cells (ILC2s) plays an important role in the development of type 2 inflammation–related diseases such as asthma and pulmonary fibrosis. Notably, neural signals are increasingly recognized as pivotal regulators of ILC2s. However, how ILC2s intrinsically modulate their responsiveness to these neural signals is still largely unknown. Here, using single-cell RNA-Seq
-
Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cells J. Clin. Invest. (IF 13.3) Pub Date : 2024 Sarah Hamze Sinno, Joshua A. Imperatore, Shoumei Bai, Noémie Gomes-Jourdan, Nyasha Mafarachisi, Claudia Coronnello, Linan Zhang, Eldin Jašarević, Hatice U. Osmanbeyoglu, Ronald J. Buckanovich, Sandra Cascio
Tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) play a critical role in resistance to immunotherapy. In this study, we identified epidermal growth factor-like 6 (Egfl6) as a regulator of myeloid cell functions. Our analyses indicated that Egfl6, via binding with β3 integrins and activation of p38 and SYK signaling, acts as a chemotactic factor for myeloid cell migration
-
CRISPR/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA J. Clin. Invest. (IF 13.3) Pub Date : 2024 Honghe Liu, Xiao-Feng Zhao, Yu-Ning Lu, Lindsey R. Hayes, Jiou Wang
A hexanucleotide GGGGCC repeat expansion in the non-coding region of the C9orf72 gene is the most common genetic mutation identified in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The resulting repeat RNA and dipeptide repeat proteins from non-conventional repeat translation have been recognized as important markers associated with the diseases. CRISPR/Cas13d
-
Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia J. Clin. Invest. (IF 13.3) Pub Date : 2024 Rafael Ferraz-Bannitz, Berkcan Ozturk, Cameron Cummings, Vissarion Efthymiou, Pilar Casanova Querol, Lindsay Poulos, Hanna Wang, Valerie Navarrete, Hamayle Saeed, Christopher M. Mulla, Hui Pan, Jonathan M. Dreyfuss, Donald C. Simonson, Darleen A. Sandoval, Mary-Elizabeth Patti
BACKGROUND. Bariatric surgery is a potent therapeutic approach for obesity and type 2 diabetes but can be complicated by post-bariatric hypoglycemia (PBH). PBH typically occurs 1–3 hours after meals, in association with exaggerated postprandial levels of incretins and insulin.
-
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors J. Clin. Invest. (IF 13.3) Pub Date : 2024 Adham S. Bear, Rebecca B. Nadler, Mark H. O’Hara, Kelsey L. Stanton, Chong Xu, Robert J. Saporito, Andrew J. Rech, Miren L. Baroja, Tatiana Blanchard, Maxwell H. Elliott, Michael J. Ford, Richard Jones, Shivang Patel, Andrea Brennan, Zachary O’Neil, Daniel J. Powell Jr., Robert H. Vonderheide, Gerald P. Linette, Beatriz M. Carreno
BACKGROUND. Neoantigens derived from KRASMUT have been described, but the fine antigen specificity of T cell responses directed against these epitopes is poorly understood. Here, we explore KRASMUT immunogenicity and the properties of 4 T cell receptors (TCRs) specific for KRASG12V restricted to the HLA-A3 superfamily of class I alleles.
-
West Nile virus triggers intestinal dysmotility via T cell–mediated enteric nervous system injury J. Clin. Invest. (IF 13.3) Pub Date : 2024 Hana Janova, Fang R. Zhao, Pritesh Desai, Matthias Mack, Larissa B. Thackray, Thaddeus S. Stappenbeck, Michael S. Diamond
Intestinal dysmotility syndromes have been epidemiologically associated with several antecedent bacterial and viral infections. To model this phenotype, we previously infected mice with the neurotropic flavivirus West Nile virus (WNV) and demonstrated intestinal transit defects. Here, we found that within 1 week of WNV infection, enteric neurons and glia became damaged, resulting in sustained reductions
-
IL-13 induces loss of CFTR in ionocytes and reduces airway epithelial fluid absorption J. Clin. Invest. (IF 13.3) Pub Date : 2024 Guillermo S. Romano Ibarra, Lei Lei, Wenjie Yu, Andrew L. Thurman, Nicholas D. Gansemer, David K. Meyerholz, Alejandro A. Pezzulo, Paul B. McCray, Ian M. Thornell, David A. Stoltz
The airway surface liquid (ASL) plays a crucial role in lung defense mechanisms, and its composition and volume are regulated by the airway epithelium. The cystic fibrosis transmembrane conductance regulator (CFTR) is abundantly expressed in a rare airway epithelial cell type called an ionocyte. Recently, we demonstrated that ionocytes can increase liquid absorption through apical CFTR and basolateral
-
Modeling primary microcephaly with human brain organoids reveals fundamental roles of CIT kinase activity J. Clin. Invest. (IF 13.3) Pub Date : 2024 Gianmarco Pallavicini, Amanda Moccia, Giorgia Iegiani, Roberta Parolisi, Emily R. Peirent, Gaia Elena Berto, Martina Lorenzati, Rami Y. Tshuva, Alessia Ferraro, Fiorella Balzac, Emilia Turco, Shachi U. Salvi, Hedvig F. Myklebust, Sophia Wang, Julia Eisenberg, Maushmi Chitale, Navjit S. Girgla, Enrica Boda, Orly Reiner, Annalisa Buffo, Ferdinando Di Cunto, Stephanie L. Bielas
Brain size and cellular heterogeneity are tightly regulated by species-specific proliferation and differentiation of multipotent neural progenitor cells (NPCs). Errors in this process are among the mechanisms of primary hereditary microcephaly (MCPH), a group of disorders characterized by reduced brain size and intellectual disability. Biallelic citron rho-interacting serine/threonine kinase (CIT)
-
Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis J. Clin. Invest. (IF 13.3) Pub Date : 2024 Federico Fondelli, Jana Willemyns, Roger Domenech-Garcia, Maria José Mansilla, Gerard Godoy-Tena, Anna G. Ferreté-Bonastre, Alex Agúndez-Moreno, Silvia Presas-Rodriguez, Cristina Ramo-Tello, Esteban Ballestar, Eva Martínez-Cáceres
Multiple sclerosis (MS) is a chronic disease characterized by dysregulated self-reactive immune responses that damage the neurons’ myelin sheath, leading to progressive disability. The primary therapeutic option, immunosuppressants, inhibits pathogenic anti-myelin responses but depresses the immune system. Antigen-specific monocyte-derived autologous tolerogenic dendritic cells (tolDCs) offer alternative
-
A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19 J. Clin. Invest. (IF 13.3) Pub Date : 2024 Valentina Trimarco, Raffaele Izzo, Stanislovas S. Jankauskas, Mario Fordellone, Giuseppe Signoriello, Maria Virginia Manzi, Maria Lembo, Paola Gallo, Giovanni Esposito, Roberto Piccinocchi, Francesco Rozza, Carmine Morisco, Pasquale Mone, Gaetano Piccinocchi, Fahimeh Varzideh, Bruno Trimarco, Gaetano Santulli
BACKGROUND. Recent studies conducted in individuals who survived COVID-19 suggest that SARS-CoV-2 infection is associated with an increased risk of dyslipidemia. However, it remains unclear whether this augmented risk is confirmed in the general population and how this phenomenon is affecting the overall burden of cardiometabolic diseases.
-
Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia J. Clin. Invest. (IF 13.3) Pub Date : 2024 Marilia Sanches Santos Rizzo Zuttion, Tanyalak Parimon, Stephanie A. Bora, Changfu Yao, Katherine Lagree, Catherine A. Gao, Richard G. Wunderink, Georgios D. Kitsios, Alison Morris, Yingze Zhang, Bryan J. McVerry, Matthew E. Modes, Alberto M. Marchevsky, Barry R. Stripp, Christopher M. Soto, Ying Wang, Kimberly Merene, Silvia Cho, Blandine L. Victor, Ivan Vujkovic-Cvijin, Suman Gupta, Suzanne L. Cassel
A leading cause of mortality after influenza infection is the development of a secondary bacterial pneumonia. In the absence of a bacterial superinfection, prescribing antibacterial therapies is not indicated but has become a common clinical practice for those presenting with a respiratory viral illness. In a murine model, we found that antibiotic use during influenza infection impaired the lung innate
-
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma J. Clin. Invest. (IF 13.3) Pub Date : 2024 Divya Nagarajan, Rebeca T. Parracho, David Corujo, Minglu Xie, Ginte Kutkaite, Thale K. Olsen, Marta Rubies Bedos, Maede Salehi, Ninib Baryawno, Michael P. Menden, Xingqi Chen, Marcus Buschbeck, Yumeng Mao
Childhood neuroblastoma with MYCN amplification is classified as high risk and often relapses after intensive treatments. Immune checkpoint blockade therapy against the PD-1/L1 axis shows limited efficacy in patients with neuroblastoma, and the cancer intrinsic immune regulatory network is poorly understood. Here, we leverage genome-wide CRISPR/Cas9 screens and identify H2AFY as a resistance gene to
-
Proteogenomic analysis integrated with electronic health records data reveals disease-associated variants in Black Americans J. Clin. Invest. (IF 13.3) Pub Date : 2024 Usman A. Tahir, Jacob L. Barber, Daniel E. Cruz, Meltem Ece Kars, Shuliang Deng, Bjoernar Tuftin, Madeline G. Gillman, Mark D. Benson, Jeremy M. Robbins, Zsu-Zsu Chen, Prashant Rao, Daniel H. Katz, Laurie Farrell, Tamar Sofer, Michael E. Hall, Lynette Ekunwe, Russell P. Tracy, Peter Durda, Kent D. Taylor, Yongmei Liu, W. Craig Johnson, Xiuqing Guo, Yii-Der Ida Chen, Ani W. Manichaikul, Deepti Jain
BACKGROUND. Most GWAS of plasma proteomics have focused on White individuals of European ancestry, limiting biological insight from other ancestry-enriched protein quantitative loci (pQTL).
-
Flavin-containing monooxygenase 2 confers cardioprotection in ischemia models through its disulfide-bond catalytic activity. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-31 Qingnian Liu,Jiniu Huang,Hao Ding,Yue Tao,Jinliang Nan,Changchen Xiao,Yingchao Wang,Rongrong Wu,Cheng Ni,Zhiwei Zhong,Wei Zhu,Jinghai Chen,Chenyun Zhang,Xiao He,Danyang Xiong,Xinyang Hu,Jian'an Wang
Myocardial infarction (MI) is characterized by massive cardiomyocytes death and cardiac dysfunction, and effective therapies to achieve cardioprotection are sorely needed. Here we reported that flavin containing monooxygenase 2 (FMO2) level was markedly increased in cardiomyocytes both in ex vivo and in vivo models of ischemia injury. Genetic deletion of FMO2 resulted in reduced cardiomyocyte survival
-
TMED4 facilitates Treg suppressive function via ROS homeostasis in tumor and autoimmune mouse models. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-31 Zhenyan Jiang,Huizi Wang,Xiaoxia Wang,Hongrui Duo,Yuexiao Tao,Jia Li,Xin Li,Jiamin Liu,Jun Ni,Emily Jiatong Wu,Hongrui Xiang,Chenyang Guan,Xinyu Wang,Kun Zhang,Peng Zhang,Zhaoyuan Hou,Yong Liu,Zhengting Wang,Bing Su,Bo Li,Youjin Hao,Bin Li,Xuefeng Wu
Endoplasmic reticulum stress (ERS) plays crucial roles in maintaining regulatory T cells (Treg) stability and function, yet the underlying mechanism remains largely unexplored. Here we demonstrate that ERS-related protein transmembrane p24 trafficking protein 4 (TMED4) Treg-specific knockout (Tmed4ΔTreg) mice contain more Treg cells with impaired Foxp3 stability, Treg signature and suppressive activity
-
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-31 Saptarshi Sinha,Brennan W Callow,Alex P Farfel,Suchismita Roy,Siyi Chen,Maria Masotti,Shrila Rajendran,Johanna M Buschhaus,Celia R Espinoza,Kathryn E Luker,Pradipta Ghosh,Gary D Luker
Estrogen receptor-positive (ER+) breast cancer commonly disseminates to bone marrow, where interactions with mesenchymal stromal cells (MSCs) shape disease trajectory. We modeled these interactions with tumor-MSC co-cultures and used an integrated transcriptome-proteome-network-analyses workflow to identify a comprehensive catalog of contact-induced changes. Conditioned media from MSCs failed to recapitulate
-
Leptin signaling maintains autonomic stability during severe influenza infection in mice. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-31 Andrés R Muñoz-Rojas,Adam C Wang,Lisa E Pomeranz,Elizabeth L Reizis,Heather W Stout-Delgado,Ileana C Miranda,Krishnan Rajagopalan,Tadiwanashe Gwatiringa,Roger R Fan,Ahmad A Huda,Neha Maskey,Roseline P Olumuyide,Aryan S Patel,Jeffrey M Friedman,Diane Mathis,Kartik N Rajagopalan
-
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-29 Brad H Nelson,Phineas T Hamilton,Minh Tung Phung,Katy Milne,Bronwyn Harris,Shelby Thornton,Donald Li Stevens,Shreena Kalaria,Karanvir Singh,Céline M Laumont,Elena Moss,Aliya Alimujiang,Nicola S Meagher,Adelyn Bolithon,Sian Fereday,Catherine J Kennedy,Joy Hendley,Dinuka Ariyaratne,Kathryn Alsop,Nadia Traficante,Ellen L Goode,Anthony N Karnezis,Hui Shen,Jean Richardson,Cindy McKinnon Deurloo,Anne Chase
BACKGROUND Despite an overall poor prognosis, about 15% of patients with advanced-stage tubo-ovarian high-grade serous carcinoma (HGSC) survive ten or more years after standard treatment. METHODS We evaluated the tumor microenvironment of this exceptional, understudied group using a large international cohort enriched for long-term survivors (LTS; 10+ years; n = 374) compared to medium-term (MTS; 5-7
-
Non-classical action of Ku70 promotes Treg suppressive function through a FOXP3-dependent mechanism in lung adenocarcinoma. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-24 Qianru Huang,Na Tian,Jianfeng Zhang,Shiyang Song,Hao Cheng,Xinnan Liu,Wenle Zhang,Youqiong Ye,Yanhua Du,Xueyu Dai,Rui Liang,Dan Li,Sheng-Ming Dai,Chuan Wang,Zhi Chen,Qianjun Zhou,Bin Li
Ku70, a DNA repair protein, binds to the damaged DNA ends and orchestrates the recruitment of other proteins to facilitate repair of DNA double-strand breaks. Besides its essential role in DNA repair, several studies have highlighted non-classical functions of Ku70 in cellular processes. However, its function in immune homeostasis and anti-tumor immunity remains unknown. Here, we discovered a marked
-
Frameshift mutation spectra overlap between constitutional mismatch repair deficiency tumors and Lynch syndrome tumors. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Yurong Song,Ryan N Baugher,Todd B Young,Brandon Somerville,Yuriko Mori,Ligia A Pinto,Kim E Nichols,Robert H Shoemaker
-
MOGAT3-Mediated DAG Accumulation Drives Acquired Resistance to Anti-BRAF/EGFR Therapy in BRAFV600E-Mutant Metastatic Colorectal Cancer. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Jiawei Wang,Huogang Wang,Wei Zhou,Xin Luo,Huijuan Wang,Qing Meng,Jiaxin Chen,Xiaoyu Chen,Yinqiang Liu,David W Chan,Zhenyu Ju,Zhangfa Song
BRAFV600E-mutant metastatic colorectal cancer (mCRC) is associated with poor prognosis. The combination of anti-BRAF/EGFR (encorafenib/cetuximab) treatment for patients with BRAFV600E-mutant mCRC improved clinical benefits; unfortunately, inevitable acquired resistance limits the treatment outcome, and the mechanism has not been validated. Here, we discovered that monoacylglycerol O-Acyltransferase
-
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Ting-Yu Chang,Yan Yan,Zih-Yao Yu,Moeez Rathore,Nian-Zhe Lee,Hui-Ju Tseng,Li-Hsin Cheng,Wei-Jan Huang,Wei Zhang,Ernest R Chan,Yulan Qing,Ming-Lun Kang,Rui Wang,Kelvin K Tsai,John J Pink,William E Harte,Stanton L Gerson,Sung-Bau Lee
The elevated level of replication stress is an intrinsic characteristic of cancer cells. Targeting the mechanisms that maintain genome stability to further increase replication stress and thus induce severe genome instability has become a promising approach for cancer treatment. Here, we identify histone deacetylase 8 (HDAC8) as a drug target whose inactivation synergizes with the inhibition of checkpoint
-
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Ru M Wen,Jessica C Stark,G Edward W Marti,Zenghua Fan,Aram Lyu,Fernando Jose Garcia Marques,Xiangyue Zhang,Nicholas M Riley,Sarah M Totten,Abel Bermudez,Rosalie Nolley,Hongjuan Zhao,Lawrence Fong,Edgar G Engleman,Sharon J Pitteri,Carolyn R Bertozzi,James D Brooks
Prostate cancer is the second leading cause of male cancer death in the U.S. Current immune checkpoint inhibitor-based immunotherapies have improved survival for many malignancies; however, they have failed to prolong survival for prostate cancer. Siglecs (sialic acid-binding immunoglobulin-like lectins) are expressed on immune cells and regulate immune responses and function. Siglec-7 and Siglec-9
-
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Laura Ondrisova,Vaclav Seda,Krystof Hlavac,Petra Pavelkova,Eva Hoferkova,Giorgia Chiodin,Lenka Kostalova,Gabriela Mladonicka Pavlasova,Daniel Filip,Josef Vecera,Pedro Faria Zeni,Jan Oppelt,Zuzana Kahounova,Rachel Vichova,Karel Soucek,Anna Panovska,Karla Plevova,Sarka Pospisilova,Martin Simkovic,Filip Vrbacky,Daniel Lysak,Stacey M Fernandes,Matthew S Davids,Alba Maiques-Diaz,Stella Charalampopoulou
BTK inhibitor therapy induces peripheral blood lymphocytosis in chronic lymphocytic leukemia (CLL) lasting for several months. It remains unclear whether non-genetic adaptation mechanisms exist, allowing CLL cells' survival during BTK inhibitor-induced lymphocytosis and/or playing a role in therapy resistance. We show that in approximately 70 % of CLL cases, ibrutinib treatment in vivo increases Akt
-
Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy associated TPM1 variants. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Saiti S Halder,Michael J Rynkiewicz,Lynne Kim,Meaghan Barry,Ahmed Ga Zied,Lorenzo R Sewanan,Jonathan A Kirk,Jeffrey R Moore,William Lehman,Stuart G Campbell
Hypertrophic and dilated cardiomyopathies (HCM and DCM, respectively) are inherited disorders that may be caused by mutations to the same sarcomeric protein but have completely different clinical phenotypes. The precise mechanisms by which point mutations within the same gene bring about phenotypic diversity remain unclear. Our objective has been to develop a mechanistic explanation of diverging phenotypes
-
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Ye Ji Choi,Gabriel Richard,Guanshi Zhang,Jeffrey B Hodgin,Dawit S Demeke,Yingbao Yang,Jennifer A Schaub,Ian M Tamayo,Bhupendra K Gurung,Abhijit S Naik,Viji Nair,Carissa Birznieks,Alexis MacDonald,Phoom Narongkiatikhun,Susan Gross,Lynette Driscoll,Maureen Flynn,Kalie Tommerdahl,Kristen J Nadeau,Viral N Shah,Tim Vigers,Janet K Snell-Bergeon,Jessica Kendrick,Daniel H van Raalte,Lu-Ping Li,Pottumarthi
BACKGROUND In type 1 diabetes (T1D), impaired insulin sensitivity may contribute to the development of diabetic kidney disease (DKD) through alterations in kidney oxidative metabolism. METHODS Young adults with T1D (n = 30) and healthy controls (HC, n = 20) underwent hyperinsulinemic-euglycemic clamp studies, MRI, 11C-acetate PET, kidney biopsies, single-cell RNA sequencing, and spatial metabolomics
-
DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Allison Joy Nielsen,Gabriella Kyra Albert,Amelia Sanchez,Jiangli Chen,Jing Liu,Andres Sebastian Davalos,Degui Geng,Xander G Bradeen,Jennifer D Hintzsche,William Robinson,Martin McCarter,Carol M Amato,Richard Tobin,Kasey L Couts,Breelyn Ann Wilky,Eduardo Davila
Effective antitumor T cell activity relies on the expression and MHC presentation of tumor neoantigens. Tumor cells can evade T cell detection by silencing the transcription of antigens or by altering MHC machinery resulting in inadequate neoantigen-specific T cell activation. We identified DNA-PK inhibitor (DNA-PKi) NU7441 as a promising immunomodulator that reduced immunosuppressive proteins while
-
Activation of Gs signaling in mouse enteroendocrine K-cells greatly improves obesity- and diabetes-related metabolic deficits. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-22 Antwi-Boasiako Oteng,Liu Liu,Yinghong Cui,Oksana Gavrilova,Huiyan Lu,Min Chen,Lee S Weinstein,Jonathan E Campbell,Jo E Lewis,Fiona M Gribble,Frank Reimann,Jürgen Wess
Following a meal, glucagon-like peptide-1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP), the two major incretins promoting insulin release, are secreted from specialized enteroendocrine cells (L- and K-cells, respectively). Although GIP is the dominant incretin in humans, the detailed molecular mechanisms governing its release remain to be explored. GIP secretion is regulated by the
-
Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice. J. Clin. Invest. (IF 13.3) Pub Date : 2024-10-17 Sarah Sanchez,Tanushree Dangi,Bakare Awakoaiye,Min Han Lew,Nahid Irani,Slim Fourati,Pablo Penaloza-MacMaster
mRNA vaccines have demonstrated efficacy during the COVID-19 pandemic and are now being investigated for multiple diseases. However, concerns linger about the durability of immune responses, and the high incidence of breakthrough infections among vaccinated individuals highlights the need for improved mRNA vaccines. In this study, we investigated the effects of reinforcing costimulation via 4-1BB,
-
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation J. Clin. Invest. (IF 13.3) Pub Date : 2024 Jonathan Bohlen, Ivan Bagarić, Taja Vatovec, Masato Ogishi, Syed F. Ahmed, Axel Cederholm, Lori Buetow, Steicy Sobrino, Corentin Le Floc’h, Carlos A. Arango-Franco, Luis Seabra, Marine Michelet, Federica Barzaghi, Davide Leardini, Francesco Saettini, Francesca Vendemini, Francesco Baccelli, Albert Catala, Eleonora Gambineri, Marinella Veltroni, Yurena Aguilar de la Red, Gillian I. Rice, Filippo Consonni
Patients heterozygous for germline CBL loss-of-function (LOF) variants can develop myeloid malignancy, autoinflammation, or both, if some or all of their leukocytes become homozygous for these variants through somatic loss of heterozygosity (LOH) via uniparental isodisomy. We observed an upregulation of the inflammatory gene expression signature in whole blood from these patients, mimicking monogenic
-
Conversations with JCI editors in chief J. Clin. Invest. (IF 13.3) Pub Date : 2024 Ushma S. Neill
Conversations with Giants in Medicine
-
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures J. Clin. Invest. (IF 13.3) Pub Date : 2024 Chester J. Kao, Soren Charmsaz, Stephanie L. Alden, Madelena Brancati, Howard L. Li, Aanika Balaji, Kabeer Munjal, Kathryn Howe, Sarah Mitchell, James Leatherman, Ervin Griffin, Mari Nakazawa, Hua-Ling Tsai, Ludmila Danilova, Chris Thoburn, Jennifer Gizzi, Nicole E. Gross, Alexei Hernandez, Erin M. Coyne, Sarah M. Shin, Jayalaxmi Suresh Babu, George W. Apostol, Jennifer Durham, Brian J. Christmas,
BACKGROUND. Immune-related adverse events (irAEs) and their associated morbidity/mortality are a key concern for patients receiving immune checkpoint inhibitors (ICIs). Prospective evaluation of the drivers of irAEs in a diverse pan-tumor cohort is needed to identify patients at greatest risk and to develop rational treatment and interception strategies.
-
Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants J. Clin. Invest. (IF 13.3) Pub Date : 2024 Lorenza Bellusci, Hana Golding, Surender Khurana
To the Editor: Prophylactic or early post-exposure treatments with SARS-CoV-2–specific monoclonal antibodies (mAbs) were useful early in the COVID-19 pandemic. However, the currently circulating SARS-CoV-2 Omicron subvariants (e.g., XBB.1, JN.1 and its derivatives) are resistant to all approved mAb therapies (1). Immunoglobulin products (IGs) manufactured from pooled human plasma are widely used for
-
An emerging multi-omic understanding of the genetics of opioid addiction J. Clin. Invest. (IF 13.3) Pub Date : 2024 Eric O. Johnson, Heidi S. Fisher, Kyle A. Sullivan, Olivia Corradin, Sandra Sanchez-Roige, Nathan C. Gaddis, Yasmine N. Sami, Alice Townsend, Erica Teixeira Prates, Mirko Pavicic, Peter Kruse, Elissa J. Chesler, Abraham A. Palmer, Vanessa Troiani, Jason A. Bubier, Daniel A. Jacobson, Brion S. Maher
Opioid misuse, addiction, and associated overdose deaths remain global public health crises. Despite the tremendous need for pharmacological treatments, current options are limited in number, use, and effectiveness. Fundamental leaps forward in our understanding of the biology driving opioid addiction are needed to guide development of more effective medication-assisted therapies. This Review focuses
-
Calcineurin inhibitor blocks tolerance by suppressing donor T cell terminal exhaustion after allogeneic hematopoietic cell transplantation J. Clin. Invest. (IF 13.3) Pub Date : 2024 Hajime Senjo, Daigo Hashimoto, Takanori Teshima
Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD Yewei Wang, … , Ping Zhang, Geoffrey R. Hill Yewei Wang, … , Ping Zhang, Geoffrey R. Hill Calcineurin inhibition mitigates exhaustion and rescues alloreactive central memory T cells in mice following bone marrow transplant. Research Article Immunology Transplantation
-
Distinguishing between help and harm: Helper T cell subsets and immune-related adverse events J. Clin. Invest. (IF 13.3) Pub Date : 2024 Alexandra M. Haugh, Adil I. Daud
The precise conditions by which cytokines drive cancer is relevant to improving immune checkpoint inhibition (ICI) responses while decreasing toxicity. In this issue of the JCI, Kao et al. investigated T helper cell pathways in patients with solid tumors receiving ICI. The authors evaluated T cell populations, cytokine signatures, immune related adverse events (irAEs), and survival outcomes. Patients